Background: Injectable fillers are sometimes necessary to correct slight skin irregularities. However, there have been reports of necrosis after injection of alloplastic materials and heterogeneous transplants. On the other hand, the advantages of autogenous tissue grafts over those fillers are well established. Volumetric reshaping of the face with autologous tissue injection is a popular and reliable method with good long-term results. However, procedures performed on the fragile skin of the nose are prone to complications. Objectives: The author conducted a study of injectable autologous microfat grafting to the nose in patients with secondary nasal deformities. Methods: During a 5-year period, 313 patients who had secondary nasal deformities with slight skin irregularities or severe nasal skin damage were treated with microfat grafting. At each patient's first injection session, excess harvested fat was cryopreserved for subsequent injection. To correct minor irregularities, 0.3 to 0.8 mL of microfat was injected during each session; for major irregularities or defects, 1 to 6 mL was required for each session. Results: One to 3 injections of microfat provided satisfactory results in all patients who had minor irregularities. For patients with multiple and severe irregularities, 3 to 6 injections were necessary and resulted in high patient satisfaction. In another group of patients, with severe traumatic skin damage, 6 to 16 injections were necessary for reconstruction. After repeated injections, each patient's skin damage was repaired. Conclusions: Autologous microfat injection appears to be safe and effective for correcting slight irregularities of the nose.
Rhinoplasty
Various injectable materials have been utilized for facial softtissue contouring, including autologous material (free fat, dermis), heterogeneous material (bovine collagen), and alloplastic material (silicone, methyl-methacrylate spheres, polytetrafluoroethylene, and hyaluronic acid). [1] [2] [3] [4] [5] [6] [7] [8] [9] The advantages of autologous tissue grafts over alloplastic materials and heterogeneous transplants have been well established. Volumetric reshaping of the face with autologous tissue injection is a popular and reliable procedure that provides good long-term results.
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Methods
During a 5-year period, from 2009 to 2013, a total of 313 patients (286 women, 27 men; Table 1 ) who had secondary nasal deformities with minor skin irregularities or severe nasal skin damage underwent microfat grafting performed by the author. Patients were treated consecutively, and the follow-up period ranged from 1 to 5 years. This is a retrospective study of patients with nasal deformities and skin irregularities of the nose treated with microfat grafting with no inclusion or exclusion criteria. The study was conducted in accordance with guidelines of the Declaration of Helsinki. Prior to the study, informed consent was obtained for each patient.
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Harvesting and Preparing Fat Grafts
The abdomen and flanks were the most common sites for fat harvesting. If those regions were not adequate, fat was obtained from the trochanteric region, buttocks, or medial thigh. With the patient under general anesthesia, a small incision was made and the fat was obtained through a 10-mL syringe and 3-mm cannula. (A local anesthetic was not applied to donor sites.) Once the syringe was filled with fat, the cannula was removed from the syringe and the grafts were transferred into 10-mL Luer-Lok syringes (Becton Dickinson, Franklin Lakes, New Jersey) after removing the plunger and sealing the aperture. The sealed Luer-Lok syringes were then centrifuged at 3000 rpm for 3 minutes. The upper liquid lipid layer and the lower aqueous layer were discarded, and 1 g of first-generation cephalosporin was added for each 100 g of centrifuged fat tissue.
Protocol for Freezing and Thawing
After the required amount of fat or tissue cocktail was injected, the remainder was cryopreserved. Specimens were placed into 10-, 20-, or 50-mL sterile tubes, labeled, frozen at −196°C in a liquid nitrogen tank, and transferred to a UF 601 medical refrigerator (Electrolux, Stockholm, Sweden) for storage at −80°C. Cryopreserved graft specimens were taken from the medical refrigerator 12 hours before subsequent procedures, transferred to a standard refrigerator (−15°C), and thawed slowly at room temperature for 1 hour before injection.
Injection of Fat
The area of the nose to be injected was marked while the patient was standing. A local anesthetic mixture, comprising 20 mL of 0.5% bupivacaine, 0.50 mg of adrenaline, 30 mL of physiologic serum, and 20 mg of triamcinolone acetonide, was injected into recipient sites to decrease posttreatment edema and ecchymosis and to create vasoconstriction of vessels to diminish the risk of microembolism.
Depending on the thickness of the skin, injections were performed with either a 22-or 24-gauge intravenous cannula ( Figure 1 ). To correct minor irregularities, 0.3 to 0.8 mL of cryopreserved microfat graft material was injected 1 to 3 times; for major irregularities or defects, 1 to 6 mL was injected 3 to 6 times. For cases of severe nasal deformities with damaged skin, injections of cryopreserved microfat graft material were performed every 2 months (6-16 times).
Repeat injections were performed of the cryopreserved fat. Small amounts of fat were injected intradermally or subcutaneously, depending on the injection site. For repeated injections, patients received a local anesthetic.
Evaluation
Patients were evaluated by comparing pre-and posttreatment photographs taken in the same studio using a Nikon camera (Nikon Corp, Tokyo, Japan) with a 105-mm microlens, 2 studio flash heads, and the same film exposure, magnification, lighting, and angle.
During the first posttreatment year, patients were seen every 3 months, and photographs were obtained at every Injection sites were marked for treatment of skin irregularities that had occurred postoperatively after a primary rhinoplasty in another institute. A 22-to 24-gauge intravenous cannula was used, depending on skin thickness. For each session for a total of 3 sessions, 0.3 to 6 mL of microfat graft material was injected. clinic visit. Thereafter, follow-up and photography were performed annually. At each visit, patient and author assessments of the results were noted in the medical record. Clinical assessments were made using medical records of the treatment and graded digital photographs. In addition, subjective patient satisfaction ratings were documented in the medical records. Patients were categorized into 3 groups according to the severity of their deformities. Patients in group 1 had slight irregularities of the skin on the nose, which were considered completely resolved when the clinical appearance was scored as 3. Patients in group 2 had marked irregularities and depressions on the skin and cartilage, which were considered not completely corrected with a rating of 2 and completely corrected with a rating of 3. Patients in group 3 had severe nasal deformities with damaged skin and were considered ready to undergo reconstructive rhinoplasty with a rating of 3 ( Table 2 ). To determine patient satisfaction, ratings were made by the author and patient together, face-to-face, and results were evaluated by examining preand posttreatment clinical photographs. The overall clinical appearance of improvement was scored on a scale of 0 to 3 (0 = no improvement, 1 = minimal improvement, 2 = moderate improvement, 3 = good improvement).
ResuLts
For all patients in group 1 (n = 264), 1 to 3 injections of microfat graft material provided satisfactory results ( Figures  2-4 ). One patient in this group experienced complications after overcorrection with microfat injection, which caused severe bruising (with the threat of necrosis) that lasted 3 weeks. Complications resolved without sequelae. (See online-only Appendix at www.aestheticsurgeryjournal.com.) In group 2 (38 patients), 3 to 6 injections were necessary and resulted in patient satisfaction ( Figure 5 ). In group 3 (11 patients), 6 to 16 injections were necessary to allow further reconstruction of the nose (Table 3) . Three patients in group 3 had previously refused the forehead flap reconstruction option recommended by other physicians. For these patients, the damaged skin recovered after several sessions of microfat injection, allowing subsequent surgical intervention ( Figure 6 ). Reconstruction was possible with immediate expansion of skin flaps [36] [37] [38] [39] and insertion of a cartilage graft. Successful fat grafting after elevation of the skin flaps was considered proof of the viability of the cryopreserved graft ( Figure 7) . The nose was reconstructed with the patient's own nasal skin, and these patients were satisfied with their results (Figure 8 ). After treating the damaged skin with cryopreserved microfat grafting, no complications occurred (ie, no vascular impairment, skin necrosis, or infection). (Images of another patient are available in the online-only Appendix.) discussion Although microfat grafting for the nose is beneficial, it has not been the specific focus of many published articles, and it has been mentioned only sporadically in medical literature pertaining to general facial microfat grafting. [33] [34] [35] Because they are readily available and preferred by many physicians, various fillers have been injected to correct skin irregularities or depressions on the nose. However, if these materials are injected into the nose by inexperienced individuals, many complications can occur. 9, [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] In general, hyaluronic acid injections are currently the preferred option; they are readily available and result in relatively fewer complications than other fillers.
5,50-57 However, hyaluronic acid is not free of complications. 40, 43, [46] [47] [48] Therefore, the author and other investigators 29, 31, [33] [34] [35] recommend microfat grafting, which can correct small or severe irregularities of nasal skin. The procedure does not require grafting cartilage and should be preferred to injections of alloplastic material.
The need for additional injections may be lessened by cryopreservation of the harvested fat grafts. In a murine model, Shoshani et al 58 achieved varying results with preservation of harvested fat at −16°C and −18°C for 1 to 2 weeks. The injected fat survived in their experimental and control groups. 58 In another study, performed in isogeneic SpragueDawley rats, there was a decrease in viable adipocytes and an increase in fat cell necrosis in the animals that received stored fat relative to those that underwent immediate graft injection. 59 In that study, viability and histology of preserved fat grafts were maintained by dry freezing in liquid nitrogen at −35°C and −195°C. 60, 61 According to many studies of cryopreservation with different protocols of freezing and thawing, adding cryoprotective agents (dimethyl sulfoxide, trehalose, or glycerol) adequately protects fat grafts. [62] [63] [64] [65] [66] [67] [68] [69] Moreover, patient acceptance of results was uniformly positive with this method of cryopreservation. [30] [31] [32] Microfat grafting is indicated to correct slight skin irregularities for which cartilage grafting would not be suitable, as well as moderate skin irregularities for which fat grafting would be less invasive than cartilage grafting. Microfat grafting also may be indicated for patients who prefer the technique, do not wish to undergo revision rhinoplasty, or desire a procedure that is less expensive than revision rhinoplasty. Contraindications include nasal skin infections, active herpes infections, necrotic nasal skin, and active nasal skin furuncles. Local anesthetics with epinephrine should not be administered in heavy smokers.
concLusions
Microfat grafting appears to be effective for correcting minor irregularities of nasal skin and may be appropriate for patients who cannot undergo revision rhinoplasty. It is also an effective salvage procedure for severely damaged skin of the nose. Injection of cryopreserved fat over several sessions is well accepted by patients because cryopreservation of excess harvested fat grafts for subsequent use makes repeated fat graft harvesting unnecessary. No late complications were observed during the present study. Microfat grafting is not a replacement for, but may be a complement to, modern rhinoplasty techniques. 
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